Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $62.6B |
| Sales growthchange from the year before | -1.6% |
| Gross marginshare of sales left after the direct cost of what it sells | 74.3% |
| Net marginshare of sales kept as profit | 12.4% |
| Free-cash-flow marginspare cash generated per $100 of sales | 14.5% |
| Return on equityprofit vs. shareholders' accounting value | 9.0% |
| Debt / equitydebt vs. shareholders' accounting value | 0.75 |
| Change in share countnegative = the company is buying back its shares | +0.2% |
2 insiders bought $2.0M on the open market.
| Buckley Mortimer JDirector | BoughtAug 5 | 37,632 shat $25.52 · $960K |
| Blaylock Ronald EDirector | BoughtAug 5 | 39,231 shat $25.46 · $999K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy